Organon & Co. (OGN)
13.42
0.00 (0.00%)
USD |
NYSE |
May 19, 16:00
13.42
0.00 (0.00%)
After-Hours: 16:12
Organon Research and Development Expense (Quarterly) : 93.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 11.98B |
| Eli Lilly & Co. | 3.51B |
| Ligand Pharmaceuticals, Inc. | 2.148M |
| Veradermics, Inc. | 20.92M |
| Johnson & Johnson | 3.495B |